These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24763305)

  • 1. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
    Xin Y; Hao S; Lu J; Wang Q; Zhang L
    PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
    Xu Z; Ma W; Gao L; Xing B
    Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
    Zhou CX; Zhao JH
    Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
    Qian T; Zhang B; Qian C; He Y; Li Y
    Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
    Lu X; Xiao S; Jin C; van der Straaten T; Li X
    J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population.
    Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J
    Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
    Zhang H; Ge J; Hong H; Bi L; Sun Z
    World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
    Yang Y; Xian L
    Tumour Biol; 2014 Apr; 35(4):2905-21. PubMed ID: 24338713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis.
    Xie F; Sun Q; Zhang E; Mu Y
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.
    Hui L; Yue S; Gao G; Chang H; Li X
    Tumour Biol; 2014 Aug; 35(8):7451-7. PubMed ID: 24782032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.
    Wu Y; Lu ZP; Zhang JJ; Liu DF; Shi GD; Zhang C; Qin ZQ; Zhang JZ; He Y; Wu PF; Miao Y; Jiang KR
    Oncotarget; 2017 Jul; 8(30):50124-50132. PubMed ID: 28223548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
    Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
    Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
    Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
    Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
    Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
    Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC1 and ERCC2 polymorphisms and adult glioma.
    Wrensch M; Kelsey KT; Liu M; Miike R; Moghadassi M; Sison JD; Aldape K; McMillan A; Wiemels J; Wiencke JK
    Neuro Oncol; 2005 Oct; 7(4):495-507. PubMed ID: 16212814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
    Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
    Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma.
    Chen H; Shao C; Shi H; Mu Y; Sai K; Chen Z
    J Neurooncol; 2007 May; 82(3):257-62. PubMed ID: 17151930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis.
    Yin M; Yan J; Voutsina A; Tibaldi C; Christiani DC; Heist RS; Rosell R; Booton R; Wei Q
    Lung Cancer; 2011 Jun; 72(3):370-7. PubMed ID: 21075476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
    Lee MS; Liu CY; Su L; Christiani DC
    Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
    Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
    Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.